Correlation Between DT Cloud and Spyre Therapeutics

Can any of the company-specific risk be diversified away by investing in both DT Cloud and Spyre Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DT Cloud and Spyre Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between DT Cloud Acquisition and Spyre Therapeutics, you can compare the effects of market volatilities on DT Cloud and Spyre Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DT Cloud with a short position of Spyre Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of DT Cloud and Spyre Therapeutics.

Diversification Opportunities for DT Cloud and Spyre Therapeutics

-0.39

Correlation Coefficient

DT Cloud  Spyre Therapeutics

Very good diversification

The 3 months correlation between DYCQU and Spyre is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding DT Cloud Acquisition and Spyre Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spyre Therapeutics and DT Cloud is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DT Cloud Acquisition are associated (or correlated) with Spyre Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spyre Therapeutics has no effect on the direction of DT Cloud i.e., DT Cloud and Spyre Therapeutics go up and down completely randomly.

Pair Corralation between DT Cloud and Spyre Therapeutics

Assuming the 90 days horizon DT Cloud is expected to generate 11.14 times less return on investment than Spyre Therapeutics. But when comparing it to its historical volatility, DT Cloud Acquisition is 8.97 times less risky than Spyre Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Spyre Therapeutics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  1,817  in Spyre Therapeutics on September 17, 2024 and sell it today you would earn a total of  595.00  from holding Spyre Therapeutics or generate 32.75% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	83.87%
Values	Daily Returns

DT Cloud Acquisition  vs.  Spyre Therapeutics

DT Cloud Acquisition

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in DT Cloud Acquisition are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, DT Cloud is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Spyre Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Spyre Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest inconsistent performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Pair Trading with DT Cloud and Spyre Therapeutics

The main advantage of trading using opposite DT Cloud and Spyre Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DT Cloud position performs unexpectedly, Spyre Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spyre Therapeutics will offset losses from the drop in Spyre Therapeutics' long position.

The idea behind DT Cloud Acquisition and Spyre Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.